B. Riley analyst Dave Kang raised the firm’s price target on Viavi (VIAV) to $12 from $10 and keeps a Neutral rating on the shares. The company’s “lengthy downturn could finally be coming to an end based on its solid print and outlook,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV: